Melissa Epperly

Melissa Epperly is the current director at Roivant Sciences. Melissa has also previously worked as CFO for PsiOxus Therapeutics Ltd and R-Pharm US. Anchorage Capital Group, L.L.C. was another company where they worked and their title there was portfolio group. Goldman Sachs and Bain & Company are also companies included in their work history. Melissa started their career as an investment banking analyst at Morgan Stanley.

Melissa Epperly has an MBA from Harvard Business School and a degree in Biochemistry and Economics from the University of Virginia.